Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
MK Proteins Ltd (MKPL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543919 NSE: MKPL Edible Oil | Small Cap | MK Proteins Share Price
₹4.04 -0.02 (-0.49%)
As on 23-Sep'26 16:01
MK Proteins Ltd (MKPL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543919 NSE: MKPL Edible Oil | Small Cap | MK Proteins Share Price
₹4.04 -0.02 (-0.49%)
As on 23-Sep'26 16:01
Key Metrics
Valuation Multiples
Market Cap
₹152 Cr.
Current Price
₹4
52-Week Low / High
₹4 / 8
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
36.3
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
9.09%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
74.82%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹37.5 Cr.
Face Value
₹1
All Time Low / High
₹3.80 / 33.33
Check Before You Invest
Quality
Not GoodValuation
Somewhat UndervaluedCheck Valuation charts
Price Trend
Semi Strong
Is MK Proteins Ltd a good quality company?
MK Proteins Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does MK Proteins Ltd performance compare with that of its Peers?
Revenue growth of MK Proteins Ltd vs industry peers?
MK Proteins Ltd revenue CAGR is %, compared to the industry median CAGR of 0.00%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of MK Proteins Ltd?
Promoters hold 74.82% of the MK Proteins Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of MK Proteins Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -45.98% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
MK Proteins Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 13.1% | 11.8% | 10.6% | 8.4% | 8.5% | 29.1% | 22.8% | 19.8% | 19% | 13.5% | - |
| Value Creation Index ⓘ | -0.1 | -0.2 | -0.3 | -0.4 | -0.4 | 1.1 | 0.6 | 0.4 | 0.4 | 0.0 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 145 | 165 | 172 | 157 | 194 | 311 | 256 | 315 | 245 | 268 | 383 |
| Sales YoY Gr. | - | 13.7% | 4.3% | -8.7% | 23.8% | 60.3% | -17.8% | 23.1% | -22.1% | 9.1% | - |
| Adj EPS ⓘ | 0 | 0 | 0 | 0 | 0.1 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 |
| YoY Gr. | - | 33.3% | 0% | 0% | 25% | 460% | -3.6% | 7.4% | 3.5% | -26.7% | - |
| BVPS (₹) ⓘ | 0.1 | 0.2 | 0.4 | 0.5 | 0.5 | 0.8 | 1.1 | 1.3 | 1.6 | 1.9 | 2.1 |
| Adj Net Profit ⓘ | 0.8 | 1 | 1.4 | 1.6 | 1.8 | 10.4 | 10.2 | 10.9 | 11.2 | 8.4 | 5 |
| Cash Flow from Ops. ⓘ | -4.2 | -3.6 | -12 | 6.4 | -4.5 | 5.5 | -10.1 | -5.9 | 32.4 | -16.1 | - |
| Debt/CF from Ops. ⓘ | -6.2 | -8.6 | -2.7 | 4.1 | -6.8 | 4.5 | -3.6 | -7.6 | 0.6 | -2.3 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 7.1% | 6.6% | 1.5% | 9.1% | ||||
| Adj EPS ⓘ | 24.8% | 34.5% | -6.6% | -26.7% | ||||
| BVPSⓘ | 34.3% | 29.9% | 20.4% | 13.5% | ||||
| Share Price | - | -46% | -47.5% | -46.8% | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 28.5 | 26.9 | 14.2 | 10 | 9.9 | 43 | 29.5 | 24.3 | 20.2 | 12.9 | 6.6 |
| Op. Profit Mgn % ⓘ | 3 | 3.1 | 3.2 | 3.2 | 2.5 | 5.1 | 6.1 | 5.4 | 6.8 | 4.7 | 2.2 |
| Net Profit Mgn % ⓘ | 0.6 | 0.6 | 0.8 | 1.1 | 0.9 | 3.3 | 4 | 3.5 | 4.6 | 3.1 | 1.3 |
| Debt to Equity ⓘ | 8 | 7.7 | 2.1 | 1.5 | 1.6 | 0.9 | 0.9 | 0.9 | 0.3 | 0.5 | - |
| Working Cap Days ⓘ | 76 | 78 | 95 | 108 | 90 | 69 | 105 | 107 | 142 | 144 | 65 |
| Cash Conv. Cycle ⓘ | 47 | 59 | 76 | 93 | 78 | 55 | 89 | 91 | 114 | 109 | 54 |
Valuation of MK Proteins - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
MK Proteins Ltd FAQs
The current trading price of MK Proteins on 23-Sep-2026 16:01 is ₹4.04.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 22-Sep-2026 the market cap of MK Proteins stood at ₹152.4 Cr
The latest P/E ratio of MK Proteins as of 22-Sep-2026 is 32.45.
The latest P/B ratio of MK Proteins as of 22-Sep-2026 is 1.96.
The 52-week high of MK Proteins is ₹7.80 and the 52-week low is ₹3.80.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of MK Proteins is ₹383 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that MK Proteins Ltd is a below average quality company.
The key valuation ratios of MK Proteins Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of MK Proteins Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About MK Proteins Ltd
MK Proteins was incorporated as MK Proteins Private Limited under the provisions of the Companies Act, 1956 vide certificate of incorporation dated June 15, 2012. Subsequently, the company was converted into public limited company and the name of the company was changed to ‘MK Proteins Limited’ pursuant to shareholder’s resolution dated January 20, 2017 and vide fresh certificate of incorporation dated February 08, 2017.
The company is focussed at production of highest quality of edible oil. Its refinery is completely mechanized and it produces rice bran oil, sunflower oil etc with protein content, with controlled fibre free from oil residue, ash and sand & silica. This is possible only through sustained levels of cleaning, storage and monitoring arrangements. The company based on its extensive experience of its promoters and its standards, conforms to major specifications and customer requirements.
Its manufacturing process involves refining of Crude Oils to obtain Refined Rice Bran Oil, Canola Oil, Soya Bean Oil, Sunflower Oil and Rice Bran Bleached Oil. During the refining process certain by-products are also manufactured such as Rice Bran Fatty Acid Oil, Rice Bran Wax, Gums and Spent Earth which are also saleable. Further, it also imports crude oils, process them and sell the finished product. It also trades in both edible and non-edible oils.
Business area of the company
The company is engaged in the manufacturing of Vegetable Refined Oil and its by-products (i.e. Rice Bran Fatty, Wax, Gums and Spent Earth etc.). Further, it also imports crude oils, process them and sell the finished product. It also trades in both edible and non-edible oils.
Products of the company
- Rice bran fatty acid oil
- Rice bran wax
- Gums
- Spent earth
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
